Shaping the Future of Pharmaceutical Innovation
At DAISA Biopharma, we combine scientific expertise with advanced research capabilities to support global drug discovery and development.
About DAISA Biopharma
We are a multidisciplinary research organization specializing in Medicinal Chemistry, Process Chemistry, and Biocatalysis—delivering scalable, efficient, and sustainable solutions for complex scientific challenges.
OUR TEAM
Dr. Samad Hossain
Dr. Samad Hossain earned his Ph.D. in 2012 from the Indian Institute of Chemical Technology (IICT), Hyderabad, India, where he conducted research on natural product total synthesis under the supervision of J. S. Yadav. Following his doctoral studies, he joined Invictus Oncology as a Research Scientist, where he worked on lipid nanoparticle- and human serum albumin-based drug delivery systems for anticancer therapeutics.
In 2019, Dr. Hossain joined AAP Pharma, Hyderabad, where he was responsible for process research and development, kilogram-scale API synthesis. In 2025, he moved on from AAP Pharma to establish Daisa Biopharma. Dr. Hossain has published six research articles and holds five patents. Dr Hossain has 14+ years R&D experience in the pharmaceutical industry and have in-depth knowledge in process optimization and manufacturing of API and specialty chemicals
Dr. Bali Reddy
Dr. Perla Venkata Bali Reddy, a graduate of Sri Krishnadevaraya University, earned his Ph.D. in 2017. From 2004 to 2016, Dr. Reddy worked at GVK BIO as an Associate Scientist, contributing to contract research projects associated with DuPont. He subsequently joined Coromandel International Limited in 2016, where he worked in Process R&D to the position of Manager.
Since 2025, Dr. Reddy has been associated with Daisa Biopharma as a Scientist in Process R&D. His current research focuses on the development and optimization of processes for APIs and advanced pharmaceutical intermediates.
Dr. Kobirul Islam
Dr. Kobirul Islam earned his Ph.D. in 2017 from the Indian Institute of Technology Guwahati, where he developed novel synthetic methodologies and multicomponent reactions under the supervision of Abu T. Khan.
Following his doctoral studies, Dr. Islam was awarded NPDF Fellowship and conducted research at Bose Institute. From 2020 to 2021, he continued his research as a Postdoctoral Fellow at the IIT Roorkee, where he focused on the synthesis of heterocycle–sugar frameworks. Dr. Islam joined Coromandel International Limited, India, as an Assistant Manager in R&D in 2021, where he worked on process development of agrochemicals, specialty chemicals and intermediates. In 2024 he joined Sekhmet Pharmaventures as Associate Manager in R&D. In 2025, Dr. Kobirul joined Daisa Biopharma as an Associate Manager in R&D. Dr Kobirul has deeper knowledge in process optimization and scaling up of API/agrochemicals and specialty chemicals from laboratory to kilogram scales. Dr. Kobirul has published five research articles and holds one patents.
Discover Our Vision
Take a closer look at how our teams collaborate to transform breakthrough ideas into impactful research outcomes.
